BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29061080)

  • 1. Integration of Community Pharmacists in Transition of Care (TOC) Services: Current Trends and Pharmacist Perceptions.
    Zeleznikar EA; Kroehl ME; Perica KM; Thompson AM; Trinkley KE
    J Pharm Pract; 2019 Feb; 32(1):28-35. PubMed ID: 29061080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision-maker and staff perceptions of the pharmacist's role in transitions of care programs.
    Foster AR; Gatewood SS; Kaefer TN; Goode JKR
    J Am Pharm Assoc (2003); 2019; 59(4S):S101-S105. PubMed ID: 31080151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rural health systems' perceptions of referral to community pharmacists during transitions of care.
    Paul S; DiDonato KL; Liu Y; Hartwig DM; May J; Schramm AM
    J Am Pharm Assoc (2003); 2016; 56(5):562-567.e2. PubMed ID: 27475835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in pharmacy-based transition-of-care activities in the United States: a national survey.
    Kern KA; Kalus JS; Bush C; Chen D; Szandzik EG; Haque NZ
    Am J Health Syst Pharm; 2014 Apr; 71(8):648-56. PubMed ID: 24688039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inpatient pharmacists' patient referrals to a transitions-of-care pharmacist: Evaluation of an automated referral process.
    Kerstenetzky L; Heimerl KM; Hartkopf KJ; Hager DR
    J Am Pharm Assoc (2003); 2018; 58(5):540-546. PubMed ID: 30017369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods and Barriers to Communication Between Pharmacists During Transitions of Care.
    Wooster J; Bethishou L; Gernant SA; On PC; Candelario DM; Uppala A; Mansukhani R; Shoair OA
    J Pharm Pract; 2023 Jun; 36(3):548-558. PubMed ID: 34963352
    [No Abstract]   [Full Text] [Related]  

  • 7. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' barriers and facilitators on implementing a post-discharge home visit.
    Ensing HT; Koster ES; Sontoredjo TAA; van Dooren AA; Bouvy ML
    Res Social Adm Pharm; 2017; 13(4):811-819.e2. PubMed ID: 27663391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
    Alzubaidi H; Saidawi W; Mc Namara K
    Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' perceptions and communication of risk for alertness impairing medications.
    Jomaa I; Odisho M; Cheung JMY; Wong K; Ellis JG; Smyth T; Saini B
    Res Social Adm Pharm; 2018 Jan; 14(1):31-45. PubMed ID: 28118967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-perceived understanding of home-going medication with transitions of care services at a pediatric institution.
    Sebastian S; Thornton H; Abdel-Rasoul M; Shaffery K
    J Am Pharm Assoc (2003); 2024; 64(3):102076. PubMed ID: 38527733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacy transition of care services and rural hospital readmissions: A case study.
    Patton AP; Liu Y; Hartwig DM; May JR; Moon J; Stoner SC; Guthrie KD
    J Am Pharm Assoc (2003); 2017; 57(3S):S252-S258.e3. PubMed ID: 28412054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Information transmission to the community pharmacist after a patient's discharge from the hospital: setting up of a written medication discharge form, prospective evaluation of its impact, and survey of the information needs of the pharmacists].
    Claeys C; Dufrasne M; De Vriese C; Nève J; Tulkens PM; Spinewine A
    J Pharm Belg; 2015 Mar; (1):42-54. PubMed ID: 26571796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A developmental evaluation of an intraprofessional Pharmacy Communication Partnership (PROMPT) to improve transitions in care from hospital to community: A mixed-methods study.
    Guilcher SJT; Fernandes O; Luke MJ; Wong G; Lui P; Cameron K; Pariser P; Raco V; Kak K; Varghese S; Papastergiou J; McCarthy LM
    BMC Health Serv Res; 2020 Feb; 20(1):99. PubMed ID: 32041591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community Pharmacist Preferences in Transition of Care Communications.
    Dolan MA; Renfro CP; Ferreri SP; Shilliday BB; Ives TJ; Cavanaugh JJ
    J Pharm Pract; 2019 Oct; 32(5):524-528. PubMed ID: 29665720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacist management of discharge medication summaries in primary care.
    Wilcock M; Bearman D
    Drug Ther Bull; 2019 Dec; 57(12):179-180. PubMed ID: 31527148
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacist linkage in care transitions: From academic medical center to community.
    Bloodworth LS; Malinowski SS; Lirette ST; Ross LA
    J Am Pharm Assoc (2003); 2019; 59(6):896-904. PubMed ID: 31590926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists' perspectives.
    Kennelty KA; Chewning B; Wise M; Kind A; Roberts T; Kreling D
    Res Social Adm Pharm; 2015; 11(4):517-30. PubMed ID: 25586885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaboration between hospital and community pharmacists to address drug-related problems: The HomeCoMe-program.
    Ensing HT; Koster ES; Dubero DJ; van Dooren AA; Bouvy ML
    Res Social Adm Pharm; 2019 Mar; 15(3):267-278. PubMed ID: 29773308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.